N@N

Matt Miksic Initiated (ZBH) at Sell and Held Target at $104 on, Oct 18th, 2022

Matt Miksic of Barclays, Initiated "Zimmer Biomet Holdings, Inc." (ZBH) at Sell and Held Target at $104 on, Oct 18th, 2022.

Matt has made no other calls on ZBH in the last 4 months.

There are 7 other peers that have a rating on ZBH. Out of the 7 peers that are also analyzing ZBH, 4 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Richard Newitter of "Truist Securities" Maintained at Hold with Increased Target to $125 on, Wednesday, August 3rd, 2022
• Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $120 on, Wednesday, August 3rd, 2022
• Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $119 on, Wednesday, August 3rd, 2022
• Matthew O'Brien of "Piper Sandler" Maintained at Hold with Decreased Target to $120 on, Tuesday, August 2nd, 2022

These are the ratings of the 3 analyists that currently disagree with Matt

---

• Matthew Taylor of "Jefferies" Initiated at Sell and Held Target at $95 on, Wednesday, October 12th, 2022
• Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $138 on, Tuesday, August 2nd, 2022
• Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $120 on, Monday, July 18th, 2022

Contributing Sources

---